JDRF exists to find the cure for type 1 diabetes. We are the world's leading charitable funder of type 1 diabetes research.
JDRF exists to cure, treat and prevent type 1 diabetes and its complications through the support of medical research. We also help educate those affected by the disease, healthcare professionals and the general public.
JDRF in the UK is one of the affiliates of JDRF International, which was first established in the United States in 1970. Today there are seven affiliates in all and each operates independently. However all our research follows the same strategy, and together we fund only the best work into type 1, wherever in the world it takes place.
JDRF aims to:
- We aim to find new ways to treat type 1 diabetes and its complications, prevent type 1 from developing and find the cure for people who already have the condition.
- Through JDRF’s education initiatives, we aim to raise awareness and understanding of type 1 amongst healthcare professionals, schools and the general public.
- We also aim to raise the profile of type 1 amongst the media, government and decision makers; pushing it up the political agenda in order to secure more funding for research into the condition.
Established: September 1986
Registered Charity Number: 295716
Board members: 10
Full time staff: 55
Part time staff: 5
Phone number: 0207 7841 3640
Address: 19 Angel GateCity RoadLondon EC1V 2PTView charity accounts on the Charity Commission website
Develop glucose responsive insulin to treat type 1‘Smart’ or glucose-responsive insulins are being designed to only turn on when they’... More
Funding research to cure, treat and prevent type 1JDRF’s research strategy is focused on moving scientific discoveries into products, drug... More
Setting the immune system right in type 1 diabetesThis project is focused on curing type 1 diabetes; so far the closest we can get to this i... More
Genes, Autoimmunity & Type 1–A Prevention Projec...Our immune systems should destroy foreign substances, such as bacteria, that may harm us. ... More